Search hospitals > Washington > Auburn
MultiCare Auburn Medical Center
Claim this profileAuburn, Washington 98001
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Cervical Adenocarcinoma
123 reported clinical trials
2 medical researchers
Summary
MultiCare Auburn Medical Center is a medical facility located in Auburn, Washington. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Breast cancer, Cervical Adenocarcinoma and other specialties. MultiCare Auburn Medical Center is involved with conducting 123 clinical trials across 283 conditions. There are 2 research doctors associated with this hospital, such as Jennifer Slim and John A. Keech.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
Top PIs
Jennifer SlimMultiCare Gig Harbor Medical Park7 years of reported clinical research
Studies Parotid Gland Cancer
Studies Breast Cancer
18 reported clinical trials
50 drugs studied
John A. KeechMultiCare Auburn Medical Center10 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
12 drugs studied
Clinical Trials running at MultiCare Auburn Medical Center
Breast Cancer
Lung Cancer
Breast cancer
Non-Small Cell Lung Cancer
Parotid Gland Cancer
Pancreatic Carcinoma
Multiple Myeloma
Pancreatic Cancer
Squamous Cell Carcinoma
ALK Gene Rearrangement
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at MultiCare Auburn Medical Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.